KIORA PHARMACEUTICALS, INC. Financing Cash Flow
KIORA PHARMACEUTICALS, INC. (KPRX) reported Financing Cash Flow of $4.92 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-07
- KIORA PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $4.92M, a 1753.65% increase year-over-year.
- KIORA PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$842.00.
- KIORA PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $296.00.
- KIORA PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $0.00.
- KIORA PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for fiscal 2025 was $265.65K, a 98.29% decline from fiscal 2024.
- KIORA PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for fiscal 2024 was $15.50M, a 159.77% increase from fiscal 2023.
- KIORA PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for fiscal 2023 was $5.97M, a 30.80% decline from fiscal 2022.
- KIORA PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for fiscal 2022 was $8.62M, a 50.97% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $4.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $4.92M 10-Q · filed 2026-08-07 | $4.92M derived: sum of 3 quarters · filed 2026-08-07 | $4.92M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2026-03-31 | -$842.00 10-Q · filed 2026-05-08 | -$546.00 derived: sum of 2 quarters · filed 2026-05-08 | -$546.00 derived: sum of 3 quarters · filed 2026-05-08 | $264.81K derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-12-31 | $296.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $296.00 derived: sum of 2 quarters · filed 2026-03-25 | $265.65K derived: sum of 3 quarters · filed 2026-08-07 | $265.65K 10-K · filed 2026-03-25 | |||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $265.36K derived: sum of 2 quarters · filed 2026-08-07 | $265.36K 10-Q · filed 2025-11-07 | $265.36K derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-06-30 | $265.36K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $265.36K 10-Q · filed 2026-08-07 | $265.36K derived: sum of 3 quarters · filed 2026-08-07 | $265.36K derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-08 | $0.00 derived: sum of 2 quarters · filed 2026-05-08 | $0.00 derived: sum of 3 quarters · filed 2026-05-08 | $250.52K derived: sum of 4 quarters · filed 2026-05-08 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $0.00 derived: sum of 2 quarters · filed 2026-03-25 | $250.52K derived: sum of 3 quarters · filed 2026-03-25 | $15.50M 10-K · filed 2026-03-25 | |||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $250.52K derived: sum of 2 quarters · filed 2025-11-07 | $15.50M 10-Q · filed 2025-11-07 | $15.01M derived: sum of 4 quarters · filed 2025-11-07 | |||
| 2024-06-30 | $250.52K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $15.50M 10-Q · filed 2025-08-08 | $15.01M derived: sum of 3 quarters · filed 2025-08-08 | $15.01M derived: sum of 4 quarters · filed 2025-08-08 | |||
| 2024-03-31 | $15.25M 10-Q · filed 2025-05-09 | $14.76M derived: sum of 2 quarters · filed 2025-05-09 | $14.76M derived: sum of 3 quarters · filed 2025-05-09 | $20.70M derived: sum of 4 quarters · filed 2025-05-09 | |||
| 2023-12-31 | -$486.42K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | -$486.42K derived: sum of 2 quarters · filed 2025-03-25 | $5.45M derived: sum of 3 quarters · filed 2025-03-25 | $5.97M 10-K · filed 2025-03-25 | |||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $5.94M derived: sum of 2 quarters · filed 2024-11-08 | $6.45M 10-Q · filed 2024-11-08 | $9.70M derived: sum of 4 quarters · filed 2024-11-08 | |||
| 2023-06-30 | $5.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $6.45M 10-Q · filed 2024-08-09 | $9.70M derived: sum of 3 quarters · filed 2024-08-09 | $15.07M derived: sum of 4 quarters · filed 2024-08-09 | |||
| 2023-03-31 | $513.17K 10-Q · filed 2024-05-10 | $3.76M derived: sum of 2 quarters · filed 2024-05-10 | $9.13M derived: sum of 3 quarters · filed 2024-05-10 | $9.13M derived: sum of 4 quarters · filed 2024-05-10 | |||
| 2022-12-31 | $3.24M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $8.62M derived: sum of 2 quarters · filed 2024-03-25 | $8.62M derived: sum of 3 quarters · filed 2024-03-25 | $8.62M 10-K · filed 2024-03-25 | |||
| 2022-09-30 | $5.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $5.38M derived: sum of 2 quarters · filed 2023-11-09 | $5.38M 10-Q · filed 2023-11-09 | $5.17M derived: sum of 4 quarters · filed 2023-11-09 | |||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $0.00 10-Q · filed 2023-08-08 | -$212.28K derived: sum of 3 quarters · filed 2023-08-08 | $9.54M derived: sum of 4 quarters · filed 2023-08-08 | |||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-09 | -$212.28K derived: sum of 2 quarters · filed 2023-05-09 | $9.54M derived: sum of 3 quarters · filed 2023-05-09 | $9.54M derived: sum of 4 quarters · filed 2023-05-09 | |||
| 2021-12-31 | -$212.28K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $9.54M derived: sum of 2 quarters · filed 2023-03-23 | $9.54M derived: sum of 3 quarters · filed 2023-03-23 | $17.58M 10-K · filed 2023-03-23 | $17.80M 10-K · filed 2022-04-15 | ||
| 2021-09-30 | $9.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $9.76M derived: sum of 2 quarters · filed 2022-11-09 | $17.80M 10-Q · filed 2022-11-09 | $17.52M 10-Q · filed 2021-11-15 | $18.01M derived: sum of 4 quarters · filed 2022-11-09 | ||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $8.04M 10-Q · filed 2022-08-12 | $7.76M 10-Q · filed 2021-08-12 | $8.26M derived: sum of 3 quarters · filed 2022-08-12 | $8.26M derived: sum of 4 quarters · filed 2022-08-12 | ||
| 2021-03-31 | $8.04M 10-Q · filed 2022-07-08 | $8.26M derived: sum of 2 quarters · filed 2022-07-08 | $8.26M derived: sum of 3 quarters · filed 2022-07-08 | $8.54M derived: sum of 4 quarters · filed 2022-07-08 | |||
| 2020-12-31 | $218.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-07-07 | $218.00K derived: sum of 2 quarters · filed 2022-07-07 | $496.19K derived: sum of 3 quarters · filed 2022-07-07 | $5.00M 10-K/A · filed 2022-07-07 | |||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $278.19K derived: sum of 2 quarters · filed 2021-11-15 | $4.78M 10-Q · filed 2021-11-15 | $8.69M derived: sum of 4 quarters · filed 2021-11-15 | |||
| 2020-06-30 | $278.19K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $4.78M 10-Q · filed 2021-08-12 | $8.69M derived: sum of 3 quarters · filed 2021-08-12 | $8.67M derived: sum of 4 quarters · filed 2021-08-12 | |||
| 2020-03-31 | $4.50M 10-Q · filed 2021-05-12 | $8.41M derived: sum of 2 quarters · filed 2021-05-12 | $8.39M derived: sum of 3 quarters · filed 2021-05-12 | $8.42M derived: sum of 4 quarters · filed 2021-05-12 | |||
| 2019-12-31 | $3.91M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $3.89M derived: sum of 2 quarters · filed 2021-03-25 | $3.92M derived: sum of 3 quarters · filed 2021-03-25 | $3.92M 10-K · filed 2021-03-25 | |||
| 2019-09-30 | -$15.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $14.68K derived: sum of 2 quarters · filed 2020-11-09 | $13.11K 10-Q · filed 2020-11-09 | $123.22K derived: sum of 4 quarters · filed 2020-11-09 | |||
| 2019-06-30 | $30.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $28.86K 10-Q · filed 2020-08-06 | $138.97K derived: sum of 3 quarters · filed 2020-08-06 | $477.00K derived: sum of 4 quarters · filed 2020-08-06 | |||
| 2019-03-31 | -$1.57K 10-Q · filed 2020-05-06 | $108.54K derived: sum of 2 quarters · filed 2020-05-06 | $446.57K derived: sum of 3 quarters · filed 2020-05-06 | $11.35M derived: sum of 4 quarters · filed 2020-05-06 | |||
| 2018-12-31 | $110.11K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-04 | $448.14K derived: sum of 2 quarters · filed 2020-03-04 | $11.35M derived: sum of 3 quarters · filed 2020-03-04 | $11.30M 10-K · filed 2020-03-04 | |||
| 2018-09-30 | $338.03K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $11.24M derived: sum of 2 quarters · filed 2019-11-07 | $11.19M 10-Q · filed 2019-11-07 | $11.25M derived: sum of 4 quarters · filed 2019-11-07 | |||
| 2018-06-30 | $10.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $10.86M 10-Q · filed 2019-08-08 | $10.91M derived: sum of 3 quarters · filed 2019-08-08 | $10.90M derived: sum of 4 quarters · filed 2019-08-08 | |||
| 2018-03-31 | -$43.55K 10-Q · filed 2019-05-08 | $7.38K derived: sum of 2 quarters · filed 2019-05-08 | $4.22K derived: sum of 3 quarters · filed 2019-05-08 | $8.81M derived: sum of 4 quarters · filed 2019-05-08 | |||
| 2017-12-31 | $50.94K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $47.77K derived: sum of 2 quarters · filed 2019-03-01 | $8.85M derived: sum of 3 quarters · filed 2019-03-01 | $10.67M 10-K · filed 2019-03-01 | |||
| 2017-09-30 | -$3.16K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $8.80M derived: sum of 2 quarters · filed 2018-11-13 | $10.62M 10-Q · filed 2018-11-13 | $10.62M derived: sum of 4 quarters · filed 2018-11-13 | |||
| 2017-06-30 | $8.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | $10.62M 10-Q · filed 2018-08-03 | $10.62M derived: sum of 3 quarters · filed 2018-08-03 | ||||
| 2017-03-31 | $1.82M 10-Q · filed 2018-05-11 | $1.82M derived: sum of 2 quarters · filed 2018-05-11 | |||||
| 2016-12-31 | -$2.86K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-02 | $3.50M 10-K · filed 2018-03-02 | |||||
| 2016-09-30 | $3.50M 10-Q · filed 2017-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |